US approves high-dose opioid reversal nasal spray from Hikma
U.S. regulators on Friday approved the first high-dose nasal spray for reversing opioid overdoses. The Food and Drug Administration approved Hikma Pharmaceuticals’ Kloxxado, a spray containing 8 milligrams of naloxone — double the highest dose […]